Literature DB >> 19519385

Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds.

Milan Jokanović1, Milica Prostran.   

Abstract

During more than five decades, pyridinium oximes have been developed as therapeutic agents used in the medical treatment of poisoning with organophosphorus compounds. Their mechanism of action is reactivation of acetylcholinesterase (AChE) inhibited by organophosphorus agents. Organophosphorus compounds (OPC) are used as pesticides and developed as warfare nerve agents such as tabun, soman, sarin, VX and others. Exposure to even small amounts of an OPC can be fatal and death is usually caused by respiratory failure resulting from paralysis of the diaphragm and intercostal muscles, depression of the brain respiratory center, bronchospasm, and excessive bronchial secretions. The mechanism of OPC poisoning involves phosphorylation of the serine hydroxyl group at the active site of AChE leading to the inactivation of this essential enzyme, which has an important role in neurotransmission. AChE inhibition results in the accumulation of acetylcholine at cholinergic receptor sites, producing continuous stimulation of cholinergic fibers throughout the central and peripheral nervous systems. Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the standard pyridinium oximes (pralidoxime, trimedoxime, obidoxime, HI-6) and diazepam has been used for the treatment of organophosphate poisoning in humans. Despite enormous efforts devoted to synthesis and development of new pyridinium oximes as potential antidotes against poisoning with OPC, only four compounds have found their application in human medicine so far. However, they differ in their activity in poisoning with warfare nerve agents and pesticides and there is still no universal broad-spectrum oxime capable of protecting against all known OPC. In this article, we review data on structure-activity relationship of pyridinium oximes and discuss their pharmacological and toxicological significance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519385     DOI: 10.2174/092986709788612729

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  24 in total

1.  Study of para-Quinone Methide Precursors toward the Realkylation of Aged Acetylcholinesterase.

Authors:  Ryan J Yoder; Qinggeng Zhuang; Jeremy M Beck; Andrew Franjesevic; Travis G Blanton; Sydney Sillart; Tyler Secor; Leah Guerra; Jason D Brown; Carolyn Reid; Craig A McElroy; Özlem Doğan Ekici; Christopher S Callam; Christopher M Hadad
Journal:  ACS Med Chem Lett       Date:  2017-05-08       Impact factor: 4.345

Review 2.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

3.  Kinetic assessment of N-methyl-2-methoxypyridinium species as phosphonate anion methylating agents.

Authors:  Joseph J Topczewski; Daniel M Quinn
Journal:  Org Lett       Date:  2013-02-14       Impact factor: 6.005

Review 4.  Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.

Authors:  A R Satvik Iyengar; Abhay H Pande
Journal:  Protein J       Date:  2016-12       Impact factor: 2.371

Review 5.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

6.  (E)-4-Nitro-benzaldehyde oxime.

Authors:  Asghar Abbas; Safdar Hussain; Noureen Hafeez; Amir Badshah; Aurangzeb Hasan; Kong Mun Lo
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-21

7.  Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers.

Authors:  Zhiqing Pang; Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Weiwei Gao; Fei Wang; Erdembileg Chuluun; Pavimol Angsantikul; Soracha Thamphiwatana; Weiyue Lu; Xinguo Jiang; Liangfang Zhang
Journal:  ACS Nano       Date:  2015-06-08       Impact factor: 15.881

8.  (E)-3,5-Dimeth-oxy-benzaldehyde oxime.

Authors:  Bin Dong; Yu Zhang; Jin-Zhe Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-02

9.  Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats.

Authors:  Jana Zdarova Karasova; Jiri Kassa; Kamil Musilek; Miroslav Pohanka; Ladislav Novotny; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2009-07-07       Impact factor: 6.208

10.  Recent advances in the treatment of organophosphorous poisonings.

Authors:  Mahdi Balali-Mood; Hamidreza Saber
Journal:  Iran J Med Sci       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.